Following up on a letter they sent to Theranos Inc. earlier this month, Democrat leaders of the House Energy and Commerce Committee wrote to the FDA and CMS this week seeking more information about the agencies’ inspections and oversight of the Palo Alto, Calif.-based company’s laboratories and blood tests.